β-NaYF4:TmYb/NaYF4
|
Mesoporous silica, PEG and folic acid coating |
92 |
300 μg/mL |
HeLa cells |
24 h |
CellTiter-Glo luminescent cell viability assay |
No significant decrease in cell viability.131
|
NaYbF4:Er |
Mesoporous silica |
76 |
21.2 µM |
HeLa cells |
12 h |
CCK-8 |
Viability =~90% cell.132
|
NaYF4:Yb,Er |
PEG-oleate bilayer |
25 |
75 μg/mL |
HAEC |
24 h |
MTT |
Viability =~50% cell.133
|
NaYF4: Yb,Er and NaYF4: Yb,Tm |
Thin amine-terminated silica layer |
54, 30, 20 |
750 μg/mL |
FAR-positive KB carcinoma cells |
1 h |
Light controlled cytotoxicity |
No significant decrease in viability of cells in the presence or absence of any exposure to light excitation.134
|
NaYF4:Yb,Er |
Different coating |
Different sizes |
62.5–125 μg/mL |
Dermal fibroblasts and human epidermal linear keratinocytes (HaCaT) |
24 h |
MTT test and optical microscopy |
The fibroblast viability was not compromised by UCNPs and the viability of HaCaT cells varied from 52% to 100% based on the surface coating.136
|
NaGdF4:Yb,Er |
PEG SiO2 and SiO2–NH2
|
Different sizes: 225–379 |
2–50 μg/mL |
NIH3T3 and RAW264.7 cells |
24–48 h |
Cell culture viability (MTS), proliferation and apoptosis |
No significant toxicity by modified NPs.137
|
NaGdF4:Yb,Er,Fe |
SiO2
|
20 nm |
1000 μg/mL |
Human cervical carcinoma cell line HeLa |
24 h |
MTT |
Low cellular toxicity. Cellular viability was estimated to be greater than 89% after 24 h.138
|
BaGdF5:Yb,Er |
Glycerol |
93 nm (7%) and 178 nm (92%). |
10, 50 and 100 mg/L |
1321N1 cells |
1–3 h |
The MTT Cell, the MTS cell viability assay, Neutral Red assay |
No significant toxicity to human brain cells.139
|